[ad_1]
Biontech co-founder Ugur Sahin
© APA (AFP)
This year, two vaccines against the new coronavirus could be approved in Europe. “If all goes smoothly,” vaccine candidates from Pfizer-Biontech and Moderna could receive conditional marketing authorization “in the second half of December 2020,” EU Commission President Ursula von said on Thursday. der Leyen. Chancellor Angela Merkel (CDU) spoke of possible approvals “in December or very shortly after the turn of the year.”
Biontech co-founder Ugur Sahin also believes that delivery and approval of the corona vaccine will be possible this year. His team is working “feverishly” on it, Mainz-based news agency AFP said. In Europe, the pharmaceutical authority Ema is responsible for approval. Ema is in “daily contact” with its US counterpart, the FDA, in order to evaluate vaccine candidates at the same time as possible, von der Leyen said after a videoconference by the heads of state and government of the EU.
The Mainz-based company Biontech with its American partner Pfizer and the American company Moderna recently reported on advances in vaccine development. According to her, her vaccine candidates are about 95 percent effective. In both cases, however, a detailed publication and evaluation of the study in a scientific journal is still pending.
The EU Commission, which on behalf of the member states concludes contracts with manufacturers for the acquisition of future vaccines, already has a firm agreement with Biontech-Pfizer for the delivery of up to 300 million doses. Negotiations are still ongoing with Moderna. The head of the company, Stéphane Bancel, recently warned the EU about delays in signing the contract.
[ad_2]
